1
Antonin Holy, Hana Dvorakova, Erik Desire Alice DeClercq, Jan Marie Rene Balzarini: Antiretroviral enantiomeric nucleotide analogs. Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, Rega Stichting v z w, Max D Hensley, May 2, 2000: US06057305 (68 worldwide citation)

Resolved enantiomers of the formula ##STR1## wherein B is a purine or pyrimidine base or aza and/or deaza analogs thereof are useful in antiviral pharmaceutical compositions to treat retroviral infections.


2

3
Holy Antonin, Dvorakova Hana, Declercq Erik Desire Alice, Balzarini Jan Marie Rene: Antiretroviral enantiomeric nucleotide analogs.. Acad Of Science Czech Republic, Rega Stichting, May 24, 1995: EP0654037-A1 (2 worldwide citation)

Resolved enantiomers of formulae (IA) and (IB) wherein B is a purine or pyrimidine base or aza and/or deaza analogs thereof are useful in antiviral pharmaceutical compositions to treat retroviral infections.


4

5
Holy Antonin, Dvorakova Hana, Declercq Erik Desire Alice, Balzarini Jan Marie Rene: Compounds for use in the preparation of antiretroviral enantiomeric nucleotide analogs. Acad Of Science Czech Republic, Rega Stichting, February 24, 1999: EP0897917-A1

Compounds of the formula XI, XII and XIV are synthesised; these compounds are useful as intermediates in the synthesis of certain acyclic nucleotide analogs possessing antiviral activity.


6
Holy Antonin, Dvorakova Hana, Declercq Erik D A, Balzarini Jan M R: Analogues de nucleotides enantiomeres antiretroviraux, Antiretroviral enantiomeric nucleotide analogs. Institute Of Organic Chemistry And Biochemistry Of The Academy Of Scienc, Institute Of Organic Chemistry And Biochemistry Of The Academy Of, Rega Stichting Vzw, ROBIC, February 17, 1994: CA2141589

Resolved enantiomers of formulae (IA) and (IB) wherein B is a purine or pyrimidine base or aza and/or deaza analogs thereof are useful in antiviral pharmaceutical compositions to treat retroviral infections.


7

8

9

10


Click the thumbnails below to visualize the patent trend.